BDBM50264920 3-(2-chloro-6-fluorophenyl)-5-(1-ethyl-2-(4-fluoropiperidin-4-yl)-1H-imidazol-5-yl)isoxazole::CHEMBL497370
SMILES: CCn1c(cnc1C1(F)CCNCC1)-c1cc(no1)-c1c(F)cccc1Cl
InChI Key: InChIKey=MKXCECHNTLUQPV-UHFFFAOYSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neuronal acetylcholine receptor subunit alpha-4 (Homo sapiens (Human)) | BDBM50264920 (3-(2-chloro-6-fluorophenyl)-5-(1-ethyl-2-(4-fluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Amgen Inc. Curated by ChEMBL | Assay Description Activation of human alpha4beta2 nAChR assessed as potentiation of submaximal response to nicotine induced current | Bioorg Med Chem Lett 18: 5209-12 (2008) Article DOI: 10.1016/j.bmcl.2008.08.080 BindingDB Entry DOI: 10.7270/Q2SX6D26 | |||||||||||
More data for this Ligand-Target Pair |